Исторические аспекты нормативно-правового регулирования работы аптек как структурных подразделений медицинских организаций

Abstract

Along with the development and improvement of the structure of medical organizations, much attention is paid to the drug provision of the therapeutic and diagnostic process in them, which contributes to improving the quality of medical care.
 Our theoretical research is based on a practical analysis of empirical data of regulatory and legal acts and documents regulating the issues of drug provision of medical organizations in Russia and abroad. Structural and functional analysis by the authors was used in the study of abstract and full-text databases published in digital online resources with materials of drug provision for medical and diagnostic work; infographics and scientific articles.
 The study has revealed that a number of requirements for pharmaceutical activities of pharmacy organizations and modern requirements for drug provision for the implementation of therapeutic and diagnostic activities do not correspond to the dynamic development of drug provision for patients of medical organizations.
 We came to the conclusion that, in modern conditions of the development of medical care to the population, in general, there are enough regulatory legal acts and documents for the organization of the work of pharmacy organizations as structural divisions of medical organizations. But, if we take into account the diversity of medical organizations, their profile, the possibility of changing the structure of medical departments, directions of medical care, then this may require changing the nomenclature of ready-made and manufactured medicines in specific conditions.
 As the results of the study have shown, joint efforts of all stakeholders in pharmacy and healthcare, as well as regulators of pharmaceutical and medical activities are needed to develop standard organizational and methodological recommendations for medical organizations carrying out medical and diagnostic activities based on the best traditions of Good Pharmacy Practice (GPP) and the International Pharmaceutical Federation (FIP). At the heart of this work, in our opinion, it is necessary to organize experimental studies using functional mathematical models of pharmacy activity in a number of therapeutic and preventive medical organizations to digitalize the organization of drug provision in them with expert evaluation of the results by specialists of all interested parties.